In silico design of a novel chimeric shigella IpaB fused to C terminal of clostridium perfringens enterotoxin as a vaccine candidate

This study aimed to design a novel chimeric protein in silico to serve as a serotype-independent vaccine candidate against Shigella. The chimera contains amino acid residues 240–460 of Shigella invasion plasmid antigen B (IpaB) and the C-terminus of Clostridium perfringens enterotoxin (C-CPE). Amino...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Bioengineered
Autores principales: Arabshahi, Sina, Nayeri Fasaei, Bahar, Derakhshandeh, Abdollah, Novinrooz, Aytak
Formato: Artigo
Lenguaje:Inglês
Publicado: Taylor & Francis 2017
Materias:
Research Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5972921/
https://ncbi.nlm.nih.gov/pubmed/29091543
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21655979.2017.1373535
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares